1/20
Looks like no tags are added yet.
Pure Food and Drug act 1906
intended to prohibit the sale or inter state transportation of adulterated or misbranded drugs
labels could no longer contain false info on drug strength or purity
difficult to enforce; government had trouble proving a drugs safety or level of contamination.
Food, Drug, and Cosmetic Act 1938
response to 100 people died of poisoning from sulfa drug product
Created the FDA
Clarifies adulterated and misbranded drugs
ensure that Pharma manufacturers obtain approval before releasing new drug
Manufacturers file New Drug Application (NDA)
Durham - Humphrey Amendment 1951
Establish distinction between legend and patent drugs
Legend: Prescriptions drugs labeled with “Rx only” ; requires prescriber directions.
Patent: Requires only adequate manufacturing label directions (OTC/Non-prescription)
Authorize Pharmacist to take refill prescriptions over phone (Substances given vary)
High potential abuse drugs omitted from phone call refills.
Kefavver - Harris Amendments 1962
Response to births of 1000s of infants (mostly europe) born with sever abnormalities caused by intake of Thalidomide.
Products must be proven to be safe and effective.
Requires drug manufacturers to file NDA with FDA and provide in-depth drug animal studies before human clinical trials
FDA approval = patent protection for a period of time and compensation
Comprehensive Drug Abuse Prevention and Control Act 1970
Control Substances Act - Combat and control drug abuse and supersede federal laws regarding it.
Controlled ranked into levels of schedules I-V (Made by DEA)
DEA enforced
Poison and Prevention Act of 1970
Created to prevent accidental drug poisoning
Requires OTC and Prescription drugs to be package in child-resistant containers.
Difficult for 85% of children | Accessible to 90% of adults
Patient can sign a waiver for having a non-resistant container.
Drug Listing Act 1972
Assigned a unique code for every new drug called a National Drug Code number (NDC)
Identifies manufacturer, drug formulation, and package sizing.
Track new, discontinued, and marketed drugs
Double checks accuracy of prescriptions filled by automation
Insurance use NDC for pharmacy reimbursements.
Orphaned Drug Act 1983
Intended for patients suffering from rare disorders ( Affects < 200,000 )
Provided drug Manufacturers financial incentives.
Drug price competition and Patent Term Restoration Act 1984
Stream-lined process to equally effective drugs with generic names
Generic must demonstrate bioequivalence
Act lengthens proprietary patent licenses for brand-name drugs
Once patent expires, any manufacturer is allowed to copy and market a competing drug ( Competing drug is less costly than original )
Prescription Drug Marketing Act 1987
Protects U.S. drug supply chain from counterfeit, adulterated, subpotent, expired medications.
Prohibits selling, trading, and distribution of drug samples to persons, other than those licensed to prescribe them.
Manufacturer to reimport drug into U.S.
Anabolic Steroids Control Act 1990
After 1990, Anabolic steroids became schedule III
Regulate prescriptive access to patients who needed them for legit medical use.
Allows FDA, to enforce steroid drug standards
Confiscate and prosecute those responsible for illegal use, distribution, and important.
Omnibus Budget Reconciliation Act 1990 (OBRA - 90)
Require pharmacy personal to engage in a review drug therapy before each prescription is filled or delivered to an individual.
States establish DUR (Drug Utilization Review) - Set standards for Pharmacist - to - Patient education and counseling.
DUR and Patient counseling a necessity for Medicaid patients
Dietary Supplement Health and Education Act 1994
Provides definition and guidelines on dietary supplements, including vitamins, minerals, herbs, and nutritional supplements.
Supplement manufacturers are not required proof of efficacy or standardization to the FDA
Labels cannot make claims of curing or treating, but may state products support health.
if manufacturer make claims of curing/treating; FDA requires proof.
Health Insurance Portability and Accountability Act 1996
Protect patient confidentiality of health records
Under law pharm techs cannot reveal any patient information outside workplace.
Food and Drug Modernization Act 1997
Update drug approval process, streamlining them to accelerate time until release of newly patented drug.
Pharm. compounding sterile and non-sterile can skip FDA requirements.
More tailored prescriptions products for people with special concerns and health conditions.
Medicare Prescription Drug, Improvement, Modernization Act 2003
Medicare Modernization Act 2003
Medicare Part D, voluntary insurance plan suited for patients with economic hardships or high - medication cost.
Act encourages Pharmacist to provide and reimbursed for in-depth annual reviews of medical profiles, ongoing high cost therapies and meds for chronic conditions.
Combat Methamphetamine Epidemic act 2005
Restricted amount of OTC products containing ephedrine and pseudoephedrine (PSE) at one time or 30 day period.
PSE products behind the counter, purchaser must present legal identification.
Pharmacy employees must complete training to handle PSE.
Public Readiness and Emergency Preparedness Act 2005 (PREP)
Protects manufacturers, distributers, and health care providers from legal liability under public health emergency.
Ex. allows pharmacy technicians to administer covid-19 test, vaccines and treatments under supervision of pharmacist.
Biological Price Competition and Innovation 2009
Promote competition, reduce health care cost, expand patient access to biologic therapies.
Pathway of approval (licensed) of biological products that biosimilar/interchangeable.
Patient Protection and Affordable care act of 2010
Affordable care act
more people have access to health insurance, those uninsured or have pre-existing conditions.
Requires states to provide health insurance options.
ACA funded states must have a preferred drug list; helps patient know which drugs are covered by their insurance.
Drug Quality and Security Act of 2013
Passed as a result of contaminated medication compounded in 2012 by a small Massachusetts facility and then widely distributed to out-of-state health care settings.
Granted the FDA more authority to regular and monitor compounded drugs.
Title I : Compounding Quality Act
Title II : Drug Supply Chain Security Act